<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05060640</url>
  </required_header>
  <id_info>
    <org_study_id>78A</org_study_id>
    <nct_id>NCT05060640</nct_id>
  </id_info>
  <brief_title>ANAL PRECANCEROUS LESIONS IN HIGH-RISK PATIENTS.</brief_title>
  <acronym>PACCO</acronym>
  <official_title>PREVALENCE OF ANAL PRECANCEROUS LESIONS IN HIGH-RISK PATIENTS DETECTED BY ROUTINE COLONOSCOPY (PACCO STUDY)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Fernando Pessoa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Fernando Pessoa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      HIV-positive patients, women with a history of genital neoplasia and patients under&#xD;
      pharmacologically immunosuppression (e.g. transplanted recipients, CrohnÂ´s disease and Lupus)&#xD;
      are a high-risk population for anal human-papillomavirus infection and associated&#xD;
      complications, like anal precancerous lesions and anal squamous cell carcinoma. There is a&#xD;
      lack of information on the prevalence of anal precancerous detected by routine colonoscopy in&#xD;
      this population, by evaluating the squamocolumnar junction (the most susceptible area for&#xD;
      lesions) during this procedure. Given, the increasing incidence rates of anal squamous cell&#xD;
      carcinoma expected for the next two decades and the increase number of at-risk patients, the&#xD;
      possible benefit of routine endoscopy in the diagnosis of anal precancerous lesions needs to&#xD;
      be further explored.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Procedures in all patients:&#xD;
&#xD;
        1. Digital anorectal evaluation&#xD;
&#xD;
        2. Colonoscopy with retroflection and visualization of the anal squamocolumnar junction&#xD;
&#xD;
        3. After identification of this area 5% acetic acid will be applied.&#xD;
&#xD;
        4. Visualization under NBI/BLI.&#xD;
&#xD;
        5. Biopsies of all the suspected lesions of anal high-grade squamous lesions (HSIL).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 26, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of anal high-grade squamous intraepithelial lesions in the squamocolumnar junction detected during routine colonoscopy.</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>AIN3</condition>
  <condition>AIN2</condition>
  <condition>HSIL, High Grade Squamous Intraepithelial Lesions</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Detection of anal HSIL in a routine colonoscopy.</intervention_name>
    <description>Detection of anal HSIL in a routine colonoscopy by using acetic acid and NBI/BLI.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        HIV-positive patients, women with genital neoplasia (cervix, vulva and vagina), solid organ&#xD;
        transplanted recipients, patients with inflammatory bowel disease and patients with Lupus.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. HIV-positive patients&#xD;
&#xD;
          2. Solid transplanted recipients&#xD;
&#xD;
          3. Crohn's disease patients under immunosuppression: steroids, thiopurines, biologics&#xD;
&#xD;
          4. Patients with lupus under immunosuppression&#xD;
&#xD;
          5. Women with a previous history of genital neoplasia (high-grade lesions or cancer) in&#xD;
             the cervix, vagina or vulva.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previous anal/perianal cancer history&#xD;
&#xD;
          2. Previous known history of anal/perianal intraepithelial neoplasia&#xD;
&#xD;
          3. Pelvic radiation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Andreia Albuquerque, MD PhD</last_name>
    <phone>00351222455455</phone>
    <email>a.albuquerque.dias@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fernando Pessoa Teaching Hospital</name>
      <address>
        <city>Gondomar</city>
        <state>Porto</state>
        <zip>4420-096</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreia Albuquerque, MD PhD</last_name>
      <phone>00351965501747</phone>
      <email>a.albuquerque.dias@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 17, 2021</study_first_submitted>
  <study_first_submitted_qc>September 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2021</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Squamous Intraepithelial Lesions of the Cervix</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Carcinoma in Situ</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

